Clofarabine

Cysolvia® is one of brands under Miedykol® a high-end and certified active pharmaceutical ingredients (APIs) and pharmaceutical intermediates manufacturer in China, mainly providing various APIs products and customized production (CMO/CDMO). We produce the clofarabine product known as a type of purine nucleoside antimetabolites, developed earlist by the US Bioenvision and FDA approved. It is used by children and young adults between 1 and 21 years old who are suffering from acute lymphoblastic leukemia (ALL; a type of cancer of the white blood cells) and relapsed or refractory lymphoblastic leukemia. The final drug generally has a higher curative rate without unpredictable adverse effects. At Miedykol, we produce the well-developed and market much-needed active ingredients in making cancer targeted drugs. We also support your cancer and tumor clinical therapies with the tailored production and integrative preparation solutions. Reach out to us for further information.